SARS-CoV-2 Antiviral Peptide

Antiviral peptides as promising therapeutics against SARS-CoV-2 represent a cutting-edge approach in the fight against COVID-19. These small protein fragments are designed to target and disrupt the virus’s ability to enter and replicate within host cells, thereby mitigating infection. With the ongoing challenge of emerging variants, researchers are focusing on developing antiviral peptides as promising therapeutics against SARS-CoV-2 to enhance treatment efficacy. Their unique mechanism of action and potential for broad-spectrum antiviral activity make them an attractive addition to the arsenal of COVID-19 interventions.